Real-world comparison of the effectiveness of tofacitinib and ustekinumab in patients with ulcerative colitis: the TORUS study

IF 12 1区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY

Clinical Gastroenterology and Hepatology Pub Date : 2025-08-18 DOI:10.1016/j.cgh.2025.07.044

Anthony BUISSON, Mélanie SERRERO, Romain ALTWEGG, Thomas GUILMOTEAU, Guillaume BOUGUEN, Maria NACHURY, Aurélien AMIOT, Lucine VUITTON, Xavier TRETON, Ludovic CAILLO, Bruno PEREIRA, Mathurin FUMERY

引用次数: 0

Abstract

We compared the effectiveness of tofacitinib and ustekinumab in patients with ulcerative colitis (UC) previously exposed to at least one anti-TNF agent.

查看原文本刊更多论文

托法替尼和乌斯特金单抗在溃疡性结肠炎患者中的有效性的真实世界比较：TORUS研究

我们比较了托法替尼和乌斯特金单抗在溃疡性结肠炎（UC）患者中的有效性，UC患者先前暴露于至少一种抗tnf药物。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical Gastroenterology and Hepatology 医学-胃肠肝病学

CiteScore

16.90

自引率

4.80%

发文量

903

审稿时长

22 days

期刊介绍： Clinical Gastroenterology and Hepatology (CGH) is dedicated to offering readers a comprehensive exploration of themes in clinical gastroenterology and hepatology. Encompassing diagnostic, endoscopic, interventional, and therapeutic advances, the journal covers areas such as cancer, inflammatory diseases, functional gastrointestinal disorders, nutrition, absorption, and secretion. As a peer-reviewed publication, CGH features original articles and scholarly reviews, ensuring immediate relevance to the practice of gastroenterology and hepatology. Beyond peer-reviewed content, the journal includes invited key reviews and articles on endoscopy/practice-based technology, health-care policy, and practice management. Multimedia elements, including images, video abstracts, and podcasts, enhance the reader's experience. CGH remains actively engaged with its audience through updates and commentary shared via platforms such as Facebook and Twitter.